Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease
Conditions
Interventions
Dornase alfa
placebo
Locations
40
United States
University of Alabama
Birmingham, Alabama, United States
Childrens Hospital of LA
Los Angeles, California, United States
USC Adult CF Center
Los Angeles, California, United States
CHOC
Orange, California, United States
Capital Allergy Resp Dis Ctr
Sacramento, California, United States
Ventura County Medical Ctr
Ventura, California, United States
Start Date
March 1, 2007
Primary Completion Date
November 1, 2008
Completion Date
November 1, 2008
Last Updated
May 16, 2017
NCT02417740
NCT06616857
NCT02740868
NCT07108153
NCT07303621
NCT07274631
Lead Sponsor
Genentech, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions